Immunotherapy in Prostate Cancer

Journal Title: The Bulletin of Urooncology - Year 2009, Vol 18, Issue 2

Abstract

In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (FDA) approval of sipuleucel-T for asymptomatic or minimal symptomatic metastatic castration-resistant prostate cancer (CRPC). Despite all these developments, the patients in whom these agents should be used, sequential use and combination strategies remain unclear. In this review, mechanisms of action and survival outcomes of different immunotherapeutic agents and therapeutic cancer vaccines in mCRPC are discussed.

Authors and Affiliations

Deniz Bolat MD, Ayfer Haydaroğlu,

Keywords

Related Articles

The Auxiliary Role of Hematological Parameters in Diagnosing Localized Germ Cell Testicular Tumor

Objective: There is a lack of information about the relationship between germ cell testicular tumors and hematological parameters commonly used in other tumors. In this study, it was aimed to determine the value of hemat...

Key Steps in Robotic Simple Prostatectomy for Benign Prostatic Hyperplasia

Open prostatectomy is still an option for the surgical treatment of benign prostate hyperplasia (BPH). In this video, key steps in robotic simple prostatectomy are summarised. Robotic surgery provides a reasonable altern...

Effect of Primary Testicular Tumor Localization on Prognosis and Survival of Non-seminomatous Testis Cancer Patients

Objective: Unlike left testicular vein, right testicular vein drains into inferior vena cava. Consequently, the systemic spread of testicular cancers in each side is expected to differ based on the vascular structures of...

How Does Antibiotherapy Affect the Clinical Outcomes of the Patients with High Prostate Specific Antigen? An Observational Study

Objective: The purpose of this observational study is to investigate the effect of urologists daily practice antibiotic usage on prostate biopsy rates and clinically insignificant cancer diagnosis rates in patients with...

Download PDF file
  • EP ID EP48741
  • DOI 10.4274/uob.galenos.2018.1142
  • Views 305
  • Downloads 0

How To Cite

Deniz Bolat MD, Ayfer Haydaroğlu, (2009). Immunotherapy in Prostate Cancer. The Bulletin of Urooncology, 18(2), -. https://europub.co.uk/articles/-A-48741